ATA Action Forms Unified Advocacy for Digital Health

ATA Action Forms Unified Advocacy for Digital Health

2025-04-01 digitalcare

United States, Tuesday, 1 April 2025.
ATA Action’s acquisition of the Digital Therapeutics Alliance seeks to enhance advocacy for digital health and telehealth integration into U.S. healthcare policy, driving innovation and policy alignment.

Strategic Merger Creates Powerful Digital Health Coalition

In a landmark development on March 31, 2025, ATA Action, the advocacy arm of the American Telemedicine Association, has completed the acquisition of the Digital Therapeutics Alliance (DTA), with unanimous approval from all organizational boards [1][2]. This strategic consolidation brings together two influential organizations to create a unified platform for policy and advocacy in the digital health sector [3]. Under this new structure, DTA’s membership, leadership team, and established programs are being fully integrated into ATA Action and the ATA, forming a more comprehensive and influential healthcare technology advocacy group [4].

Leadership and Strategic Direction

The merger brings significant leadership changes and strategic expansion. Andy Molnar, formerly CEO of DTA, has assumed the role of head of digital health at ATA Action and will lead the newly formed Advancing Digital Health Coalition while serving as senior vice president of industry affairs at the ATA [3]. Kyle Zebley, executive director of ATA Action, emphasizes that the consolidated organization will focus on advancing state and federal policies to establish telehealth as a permanent healthcare modality [5]. The coalition’s scope extends beyond traditional telehealth to encompass digital therapeutics, artificial intelligence, and remote monitoring devices [2].

Policy Priorities and Regulatory Impact

The merged organization has outlined key priority areas including digital therapeutics, Prescription Drug Use Related Software (PDURS), Digital Mental Health Treatment Devices, and remote monitoring technologies [2]. This comprehensive approach leverages DTA’s established relationship with the FDA and its influence with regulatory agencies in Europe and Asia, while building on ATA Action’s successful track record in federal and state-level telehealth legislation [5]. The organization aims to ensure that digital health solutions are ‘recognized, reimbursed, and integrated into every aspect of our healthcare system’ [1].

Future Implications for Digital Healthcare

This consolidation represents a significant step toward establishing a more cohesive voice in healthcare technology advocacy. The unified platform will focus on expanding educational initiatives, leveraging combined resources, and advancing the adoption of technology-enabled care modalities [5]. With both organizations’ combined expertise, the merger positions the digital health sector for enhanced influence in shaping healthcare policies and ensuring that telehealth and digital therapeutics remain integral components of the U.S. healthcare system [4].

Bronnen


digital therapeutics telehealth